Erste Asset Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Erste Asset Management’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-12,000	Closed	-$10.3K	–	432
2019 Q4	$10.3K	Hold	12,000	–	–	﹤0.01%	394
2019 Q3	$6.72K	Hold	12,000	–	–	﹤0.01%	398
2019 Q2	$6.24K	Hold	12,000	–	–	﹤0.01%	416
2019 Q1	$5.4K	Hold	12,000	–	–	﹤0.01%	409
2018 Q4	$5.64K	Buy	+12,000	New	+$5.96K	﹤0.01%	427

Erste Asset Management's GCVRZ Position: Q1 2020 in Review

Erste Asset Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 12,000 shares — an estimated $10.3K sold.

Erste Asset Management first reported a position in GCVRZ in Q4 2018 and held it in 5 quarters. The position peaked at $10.3K in Q4 2019. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.

Erste Asset Management reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
Erste Asset Management sold 12,000 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $10.3K.
Erste Asset Management first reported a position in Sanofi Contingent Value Rights in Q4 2018 and held it in 5 quarters.
Erste Asset Management's Sanofi Contingent Value Rights position peaked at $10.3K in Q4 2019.
2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.

Based on Erste Asset Management's 13F filing for Q1 2020, filed 22 Nov 2024.